name,category,termsGTPase, IMAP family member 5,INTERPRO[450006113$IPR006703:AIG1]
GTPase, IMAP family member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000639$gtp-binding, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001063$nucleotide-binding, 790001555$transmembrane]
GTPase, IMAP family member 5,UP_SEQ_FEATURE[850022637$chain:GTPase IMAP family member 5, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Rho family GTPase 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
Rho family GTPase 2,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type]
Rho family GTPase 2,SMART[760000148$SM00174:RHO]
Rho family GTPase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
Rho family GTPase 2,UP_SEQ_FEATURE[850057605$chain:Rho-related GTP-binding protein RhoN, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region]
nuclear receptor subfamily 1, group D, member 2,INTERPRO[450000278$IPR000324:Vitamin D receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 1, group D, member 2,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 1, group D, member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 1, group D, member 2,UP_SEQ_FEATURE[850035044$chain:Nuclear receptor subfamily 1 group D member 2, 850102581$compositionally biased region:Poly-Ser, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
platelet-derived growth factor receptor, beta polypeptide,BBID[10000094$73.Integrins_and_other_cell-surface_receptors]
platelet-derived growth factor receptor, beta polypeptide,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450001615$IPR001824:Receptor tyrosine kinase, class III, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008254$IPR009134:Vascular endothelial growth factor receptor, VEGFR, N-terminal, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold, 450014567$IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
platelet-derived growth factor receptor, beta polypeptide,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038853$hsa04510:Focal adhesion, 470038858$hsa04540:Gap junction, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma]
platelet-derived growth factor receptor, beta polypeptide,OMIM_DISEASE[520003467$Myelomonocytic leukemia, chronic, 520003470$Myeloproliferative disorder with eosinophilia]
platelet-derived growth factor receptor, beta polypeptide,PIR_SUPERFAMILY[630000724$PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type, 630000725$PIRSF000615:TyrPK_CSF1-R, 630031083$PIRSF500948:beta-type platelet-derived growth factor receptor]
platelet-derived growth factor receptor, beta polypeptide,SMART[760000192$SM00219:TyrKc, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
platelet-derived growth factor receptor, beta polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000679$heterodimer, 790000701$homodimer, 790000768$Immunoglobulin domain, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001271$Proto-oncogene, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001586$tyrosine-protein kinase, 790001588$tyrosine-specific protein kinase]
platelet-derived growth factor receptor, beta polypeptide,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850007905$chain:Beta-type platelet-derived growth factor receptor, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850117850$site:Breakpoint for insertion to form PDE4DIP- PDGFRB fusion protein, 850117951$site:Breakpoint for translocation to form TRIP11-PDGFRB, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,INTERPRO[450000678$IPR000783:RNA polymerase, subunit H/Rpb5 C-terminal, 450005022$IPR005571:RNA polymerase, Rpb5, N-terminal, 450012958$IPR014381:DNA-directed RNA polymerase, RPB5 subunit]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase, 470038894$hsa05016:Huntington's disease]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,PIR_SUPERFAMILY[630000867$PIRSF000747:DNA-directed RNA polymerase, RPB5 subunit, 630000868$PIRSF000747:RPB5]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000468$dna-directed rna polymerase, 790000733$host-virus interaction, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,UP_SEQ_FEATURE[850016114$chain:DNA-directed RNA polymerases I, II, and III subunit RPABC1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
protein phosphatase 1, regulatory (inhibitor) subunit 3F,INTERPRO[450004506$IPR005036:Putative phosphatase regulatory subunit]
protein phosphatase 1, regulatory (inhibitor) subunit 3F,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
protein phosphatase 1, regulatory (inhibitor) subunit 3F,UP_SEQ_FEATURE[850047274$chain:Protein phosphatase 1 regulatory subunit 3F, 850103302$domain:CBM21, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
selenocysteine lyase,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
selenocysteine lyase,INTERPRO[450000163$IPR000192:Aminotransferase, class V/Cysteine desulfurase, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1, 450014776$IPR016454:Cysteine desulfurase, NifS]
selenocysteine lyase,KEGG_PATHWAY[470038760$hsa00450:Selenoamino acid metabolism]
selenocysteine lyase,PIR_SUPERFAMILY[630005495$PIRSF005572:cysteine desulfurase, NifS type, 630005496$PIRSF005572:NifS]
selenocysteine lyase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
selenocysteine lyase,UP_SEQ_FEATURE[850000018$active site:Cysteine persulfide intermediate, 850059259$chain:Selenocysteine lyase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
superoxide dismutase 2, mitochondrial,BIOCARTA[30000099$h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB]
superoxide dismutase 2, mitochondrial,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
superoxide dismutase 2, mitochondrial,INTERPRO[450001044$IPR001189:Manganese/iron superoxide dismutase, 450018062$IPR019831:Manganese/iron superoxide dismutase, N-terminal, 450018063$IPR019832:Manganese/iron superoxide dismutase, C-terminal, 450018064$IPR019833:Manganese/iron superoxide dismutase, binding site]
superoxide dismutase 2, mitochondrial,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
superoxide dismutase 2, mitochondrial,PIR_SUPERFAMILY[630000411$PIRSF000349:SODismutase, 630000412$PIRSF000349:superoxide dismutase, Mn/Fe specific]
superoxide dismutase 2, mitochondrial,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000906$manganese, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790001038$nitration, 790001092$oxidoreductase, 790001212$polymorphism, 790001405$signal, 790001550$transit peptide]
superoxide dismutase 2, mitochondrial,UP_SEQ_FEATURE[850062975$chain:Superoxide dismutase [Mn], mitochondrial, 850105852$helix, 850106173$metal ion-binding site:Manganese, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
von Hippel-Lindau tumor suppressor,BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000307$h_vegfPathway:VEGF, Hypoxia, and Angiogenesis]
von Hippel-Lindau tumor suppressor,INTERPRO[450002407$IPR002714:Tumour suppressor protein, von Hippel-Lindau disease]
von Hippel-Lindau tumor suppressor,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
von Hippel-Lindau tumor suppressor,OMIM_DISEASE[520002240$Hemangioblastoma, cerebellar, somatic, 520003978$Pheochromocytoma, 520004042$Polycythemia, benign familial, 520004230$Renal cell carcinoma, somatic, 520005051$von Hippel-Lindau syndrome]
von Hippel-Lindau tumor suppressor,PIR_SUPERFAMILY[630014449$PIRSF017788:von Hippel-Lindau disease tumor suppressor protein]
von Hippel-Lindau tumor suppressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000361$congenital erythrocytosis, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001580$tumor suppressor, 790001593$ubl conjugation pathway]
von Hippel-Lindau tumor suppressor,UP_SEQ_FEATURE[850100590$chain:Von Hippel-Lindau disease tumor suppressor, 850105852$helix, 850106259$mutagenesis site, 850110721$region of interest:8 X 5 AA tandem repeats of G-[PAVG]-E-E- [DAYSLE], 850112295$region of interest:Interaction with Elongin BC complex, 850113157$region of interest:Involved in binding to CCT complex, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
zinc finger protein 233,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 233,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 233,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 233,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 233,UP_SEQ_FEATURE[850101512$chain:Zinc finger protein 233, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118709$zinc finger region:C2H2-type 2; degenerate, 850118721$zinc finger region:C2H2-type 3; degenerate, 850118724$zinc finger region:C2H2-type 4; degenerate, 850118727$zinc finger region:C2H2-type 5; degenerate, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 382,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 382,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 382,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 382,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 382,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 382,UP_SEQ_FEATURE[850101606$chain:Zinc finger protein 382, 850104552$domain:KRAB, 850113394$region of interest:Mediates interaction with TRIM28, 850114215$region of interest:Represses transcription, 850114501$region of interest:Required for transcriptional repression activity; probably mediates sequence- specific DNA-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118657$zinc finger region:C2H2-type 10, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 619,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 619,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 619,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 619,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 619,UP_SEQ_FEATURE[850101798$chain:Zinc finger protein 619, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
